These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 7947384)

  • 1. c-erbA and v-erbA modulate growth and gene expression of a mouse glial precursor cell line.
    Iglesias T; Llanos S; López-Barahona M; Pérez-Aranda A; Rodríguez-Peña A; Bernal J; Höhne A; Seliger B; Muñoz A
    Cell Growth Differ; 1994 Jul; 5(7):697-704. PubMed ID: 7947384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of platelet-derived growth factor B/c-sis by the v-erbA oncogene in glial cells.
    Iglesias T; Llanos S; López-Barahona M; Seliger B; Rodríguez-Peña A; Bernal J; Muñoz A
    Oncogene; 1995 Mar; 10(6):1103-10. PubMed ID: 7700635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. v-erbA oncogene induces invasiveness and anchorage-independent growth in cultured glial cells by mechanisms involving platelet-derived growth factor.
    Llanos S; Iglesias T; Riese HH; Garrido T; Caelles C; Muñoz A
    Cell Growth Differ; 1996 Mar; 7(3):373-82. PubMed ID: 8838867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of transformation by v-ErbA: substitution for steroid hormone receptor function in self renewal induction.
    Bauer A; Ulrich E; Andersson M; Beug H; von Lindern M
    Oncogene; 1997 Aug; 15(6):701-15. PubMed ID: 9264411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of normal erythroid differentiation by the endogenous thyroid hormone and retinoic acid receptors: a possible target for v-erbA oncogene action.
    Schroeder C; Gibson L; Zenke M; Beug H
    Oncogene; 1992 Feb; 7(2):217-27. PubMed ID: 1347914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of proliferation and expression of T1 and cyclin D1 genes by thyroid hormone in mammary epithelial cells.
    González-Sancho JM; Figueroa A; López-Barahona M; López E; Beug H; Muñoz A
    Mol Carcinog; 2002 May; 34(1):25-34. PubMed ID: 12112320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The v-erbA oncogene requires cooperation with tyrosine kinases to arrest erythroid differentiation induced by ligand-activated endogenous c-erbA and retinoic acid receptor.
    Schroeder C; Gibson L; Beug H
    Oncogene; 1992 Feb; 7(2):203-16. PubMed ID: 1347913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermal growth factor (EGF), transforming growth factor-alpha (TGF-alpha), and basic fibroblast growth factor (bFGF) differentially influence neural precursor cells of mouse embryonic mesencephalon.
    Santa-Olalla J; Covarrubias L
    J Neurosci Res; 1995 Oct; 42(2):172-83. PubMed ID: 8568917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. v-erbA oncogene initiates ultrastructural changes characteristic of early and intermediate events of meiotic maturation in Xenopus oocytes.
    Nagl SB; Bunn CF; Allison LA
    J Cell Biochem; 1997 Nov; 67(2):184-200. PubMed ID: 9328824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The c-erbA alpha protooncogene induces apoptosis in glial cells via a protein kinase C- and bcl-2-suppressible mechanism.
    Llanos S; Caelles C; Azorín I; Renau-Piqueras J; Fernández-Luna JL; Boscá L; Muñoz A
    J Neurochem; 1998 Jun; 70(6):2315-26. PubMed ID: 9603196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The thyroid hormone receptor functions as a ligand-operated developmental switch between proliferation and differentiation of erythroid progenitors.
    Bauer A; Mikulits W; Lagger G; Stengl G; Brosch G; Beug H
    EMBO J; 1998 Aug; 17(15):4291-303. PubMed ID: 9687498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. v-erbA cooperates with bFGF in neuroretina cell transformation.
    Garrido C; Li RP; Samarut J; Gospodarowicz D; Saule S
    Virology; 1993 Feb; 192(2):578-86. PubMed ID: 7678474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The v-ErbA oncoprotein quenches the activity of an erythroid-specific enhancer.
    Braliou GG; Ciana P; Klaassen W; Gandrillon O; Stunnenberg HG
    Oncogene; 2001 Feb; 20(7):775-87. PubMed ID: 11314012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The v-erbA oncogene (review).
    Thormeyer D; Baniahmad A
    Int J Mol Med; 1999 Oct; 4(4):351-8. PubMed ID: 10493974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The leukaemia oncogene v-erbA: a dominant negative version of ligand dependent transcription factors that regulates red cell differentiation?
    Ghysdael J; Beug H
    Cancer Surv; 1992; 14():169-80. PubMed ID: 1358441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. v-erbA stimulates quail myoblast differentiation in a T3 independent, cell-specific manner.
    Cassar-Malek I; Marchal S; Altabef M; Wrutniak C; Samarut J; Cabello G
    Oncogene; 1994 Aug; 9(8):2197-206. PubMed ID: 7913543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Constitutive transactivation by the thyroid hormone receptor and a novel pattern of activity of its oncogenic homolog v-ErbA in Xenopus oocytes.
    Nagl SB; Nelson CC; Romaniuk PJ; Allison LA
    Mol Endocrinol; 1995 Nov; 9(11):1522-32. PubMed ID: 8584030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unliganded c-erbA/thyroid hormone receptor induces trkB expression in neuroblastoma cells.
    Pastor R; Bernal J; Rodríguez-Peña A
    Oncogene; 1994 Apr; 9(4):1081-9. PubMed ID: 8134111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dimerization of v-erbA on inverted repeats.
    Zubkova I; Subauste JS
    Biochem Biophys Res Commun; 2002 May; 294(1):35-41. PubMed ID: 12054736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. c-erbA alpha/T3R and RARs control commitment of hematopoietic self-renewing progenitor cells to apoptosis or differentiation and are antagonized by the v-erbA oncogene.
    Gandrillon O; Ferrand N; Michaille JJ; Roze L; Zile MH; Samarut J
    Oncogene; 1994 Mar; 9(3):749-58. PubMed ID: 7906409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.